ENST00000362079.2:c.173G>A

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PVS1_StrongPM2_Supporting

This summary comes from the ClinGen Evidence Repository: The m.9379G>A (p.W58Ter) variant in MT-CO3 has been reported in one individual with primary mitochondrial disease. This individual had childhood onset mitochondrial myopathy and lactic acidosis and harbored the variant at 93% heteroplasmy in muscle; however the variant was not detected in the proband's blood or hair. The variant was also undetectable in blood and hair from the healthy mother and blood from the healthy sister (PMID:12414820). This variant introduces a premature termination codon in exon 58 out of 261, and is expected to remove 78% of the protein (PVS1_strong). This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). There are no in silico predictors for this type of variant in mitochondrial DNA. In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on January 22, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID:32906214): PVS1_strong, PM2_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA120603/MONDO:0044970/015

Frequency

Mitomap GenBank:
Absent

Consequence

MT-CO3
ENST00000362079.2 stop_gained

Scores

Clinical Significance

Uncertain significance reviewed by expert panel P:2U:1O:1
MM-w-lactic-acidosis

Conservation

PhyloP100: 5.58

Publications

5 publications found
Variant links:
Genes affected
MT-CO3 (HGNC:7422): (mitochondrially encoded cytochrome c oxidase III) Predicted to enable electron transfer activity and oxidoreduction-driven active transmembrane transporter activity. Involved in respiratory chain complex IV assembly. Part of respiratory chain complex IV. Implicated in MELAS syndrome. [provided by Alliance of Genome Resources, Apr 2022]
MT-ATP6 (HGNC:7414): (mitochondrially encoded ATP synthase 6) Contributes to proton-transporting ATP synthase activity, rotational mechanism. Involved in mitochondrial ATP synthesis coupled proton transport. Part of mitochondrial proton-transporting ATP synthase complex. Implicated in Leber hereditary optic neuropathy; NARP syndrome; Parkinson's disease; multiple sclerosis; and systemic lupus erythematosus. [provided by Alliance of Genome Resources, Apr 2022]
MT-ATP6 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial disease
    Inheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen
  • NARP syndrome
    Inheritance: Mitochondrial Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • familial infantile bilateral striatal necrosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial proton-transporting ATP synthase complex deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Leber hereditary optic neuropathy
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
  • maternally-inherited Leigh syndrome
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
  • maternally-inherited spastic paraplegia
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
  • periodic paralysis with later-onset distal motor neuropathy
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PVS1
For more information check the summary or visit ClinGen Evidence Repository.
PM2
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000362079.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MT-CO3
ENST00000362079.2
TSL:6
c.173G>Ap.Trp58*
stop_gained
Exon 1 of 1ENSP00000354982.2P00414
MT-ATP6
ENST00000361899.2
TSL:6
c.*172G>A
downstream_gene
N/AENSP00000354632.2P00846

Frequencies

Mitomap GenBank
The variant is not present, suggesting it is rare.

Mitomap

Disease(s): MM-w-lactic-acidosis
Status: Reported-[VUS]
Publication(s): 12414820

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Mitochondrial complex IV deficiency, nuclear type 1 (1)
-
1
-
Mitochondrial disease (2)
1
-
-
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.40
D
PhyloP100
5.6
GERP RS
5.0
Mutation Taster
=70/30
polymorphism

Publications

Other links and lift over

dbSNP: rs267606615; hg19: chrM-9380; API